HM Capital

Dallas Biotech Secures $50M Series D Funding To Combat Rare Hidden Killer in Joint Replacements

by | Jul 16, 2024
The $50 million funding will support the commercial launch of Osteal Therapeutics' pioneering combination drug/device therapy targeting biofilm infections, which are notoriously difficult to eradicate.
Follow the Money: Rent-A-Center Nabs $19M Investment, Playful Studios Receives $23M; ReadyRosie Acquired
by | Sep 5, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies in North Texas, you’ll also find news from ACIS, TPG, HM Capital, and Fleco Industries.